Filing Flows › BioCorRx (BICX) › Q2 2026 › vs Q2 2025
BioCorRx (BICX) Q2 2026 vs Q2 2025 (year over year)
BioCorRx's revenue fell $90K (-51%) from $178K in Q2 2025 to $88K in Q2 2026.
BioCorRx, Q2 2026: revenue $88K (-51% year over year), net loss $1.0M, operating cash flow −$440K. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $88K | $178K | −$90K | -51% |
| Other income, net | $464K | $37K | $427K | 13× |
| Net loss | $1.0M | $1.4M | −$376K | -27% |
| Costs & expenses | $1.6M | $1.6M | −$39K | -2% |
| Operating costs | $1.6M | $1.6M | −$39K | -2% |
| Research & development | $712K | $297K | $416K | +140% |
| SG&A | $686K | $1.2M | −$537K | -44% |
| Other operating costs | $10K | $72K | −$62K | -86% |
| Operating cash sources | $1.0M | $1.4M | −$376K | -27% |
| Depreciation & amortization | $10K | $72K | −$62K | -86% |
| Share-based compensation | $122K | $156K | −$33K | -21% |
| Working capital & other | $429K | $1.0M | −$594K | -58% |
| Cash used in operations | $440K | $126K | $314K | +248% |
| Net loss absorbed | $1.0M | $1.4M | −$376K | -27% |
Questions
How much did BioCorRx's revenue grow year over year in Q2 2026?
BioCorRx's revenue fell $90K (-51%) from $178K in Q2 2025 to $88K in Q2 2026.